author-photo

Zuoxing Niu

Academy of Medical Sciences, United Kingdom

8

Papers

44

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association.

2020 Cancer biology and medicine
Show All
- Source
- Cite
- Save
Citations (0)
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study

2018 Chinese Medical Journal
Show All
- Source
- Cite
- Save
Citations (3)
Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model

2018 Translational Oncology
Show All
- Source
- Cite
- Save
Citations (33)
Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study.

2016 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (8)
A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)